Cargando…
Pilot dose-ranging of rhIGF-1/rhIGFBP-3 in a preterm lamb model of evolving bronchopulmonary dysplasia
BACKGROUND: Low levels of insulin-like growth factor-1 (IGF-1) protein in preterm human infants are associated with bronchopulmonary dysplasia (BPD). We used our preterm lamb model of BPD to determine: (1) dosage of recombinant human (rh) IGF-1 bound to binding protein 3 (IGFBP3) to reach infant phy...
Autores principales: | Albertine, Kurt H., Dahl, Mar Janna, Rebentisch, Andrew, Dawson, Elaine, Nabi, Akbar, Bowen, Sydney, Miers, Cindy, Wang, Zhengming, Yang, Haixia, Yu, Baifeng, Null, Donald M., Keefe, Dennis, Chung, J-K, Zhou, Z, Barton, Norman, Carey, Galen, Ward, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968819/ https://www.ncbi.nlm.nih.gov/pubmed/36030318 http://dx.doi.org/10.1038/s41390-022-02272-9 |
Ejemplares similares
-
Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications
por: Salamat-Miller, Nazila, et al.
Publicado: (2022) -
rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial
por: Ley, David, et al.
Publicado: (2018) -
Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants: Post-hoc Analysis of Its Effect on Brain Injury
por: Horsch, Sandra, et al.
Publicado: (2020) -
rhIGF-1 Therapy: A Silver Bullet for Bronchopulmonary Dysplasia
Prevention?
por: Plosa, Erin J., et al.
Publicado: (2020) -
rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia
por: Seedorf, Gregory, et al.
Publicado: (2020)